Principles for Sound Pharmacy & Therapeutics Practices: What’s Next?
Nearly 20 years have passed since AMCP and other stakeholders adopted the Principles for a Sound Formulary System. Since that time, requirements for pharmacy and therapeutics committees (P&T) have been adopted by the Medicare Part D program, health insurance marketplace plans, commercial health plans, Medicaid programs, and other public payers. Changes and evolution in health care suggest the need for updated recommendations from a broad group of stakeholders.
On March 28, 2019, in San Diego, CA, AMCP convened the stakeholder forum, Principles for Sound Pharmacy and Therapeutics (P&T) Practices: What’s Next?, to hear from thought leaders representing patients, payers, providers, government, and biopharmaceutical companies. While the perspectives of participants varied, several themes came to light:
• Variation exists in the guidelines and evidence cited in publicly available payer coverage decisions.
• The wealth of new information and data sources available for evaluating the effectiveness of drugs and devices, will require additional competencies in new evaluation techniques and methodologies by P&T committee members.
• Managed care organizations have a huge opportunity to engage and incorporate the patient perspective in coverage decisions.
• Managing conflicts of interest and establishing organizational policies on transparency are crucial and should be a priority.
The full Forum proceedings including specific recommendations and identified best practices for P&T committees to address patient centricity, use of real-world evidence, and managing transparency and conflicts of interest will be published in the Journal of Managed Care & Specialty Pharmacy in Fall 2019.